DiaMedica Therapeutics (DMAC) Prepaid Assets (2017 - 2026)

DiaMedica Therapeutics (DMAC) posted quarterly Prepaid Assets of $731000.0 for Q1 2026, up 12.63% year-over-year from $649000.0 in Q1 2025, and up 51.98% quarter-over-quarter from $481000.0 in Q4 2025.

DiaMedica Therapeutics (DMAC) Prepaid Assets (2017 - 2026) Analysis & Trends

DiaMedica Therapeutics' Prepaid Assets history runs 10 years deep, the most recent figure standing at $731000.0 for Q1 2026.

  • In Q1 2026, Prepaid Assets rose 12.63% year-over-year to $731000.0; the TTM figure through Mar 2026 stood at $731000.0 (up 12.63% YoY), while the FY2025 annual figure was $481000.0, up 111.89% from the prior year.
  • Prepaid Assets for Q1 2026 stood at $731000.0, up from $481000.0 in the prior quarter.
  • The five-year high for Prepaid Assets was $962000.0 in Q1 2023, with the low at $209000.0 in Q4 2022.
  • The 5-year median for Prepaid Assets is $534000.0 (2022), against an average of $525411.8.
  • The sharpest annual moves came in 2022 and 2024: Prepaid Assets surged 148.81% in 2022, then sank 44.77% in 2024.
  • DiaMedica Therapeutics' Prepaid Assets stood at $209000.0 in 2022, then jumped by 96.65% to $411000.0 in 2023, then tumbled by 44.77% to $227000.0 in 2024, then soared by 111.89% to $481000.0 in 2025, then jumped by 51.98% to $731000.0 in 2026.
  • Business Quant data shows DMAC's Prepaid Assets at $731000.0 in Q1 2026, $481000.0 in Q4 2025, and $445000.0 in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 128.13 Bn 120.28 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 112.33 Bn 104.33 Bn 3.93 Bn
3 Argenx Se 53.24 Bn 48.05 Bn 1.41 Bn
4 Revolution Medicines 43.64 Bn 43.64 Bn -
5 BeOne Medicines 39.27 Bn 34.17 Bn 1.53 Bn
6 MindWalk Holdings 35.32 Bn 35.31 Bn 1.82 Bn
7 Royalty Pharma 33.72 Bn 35.84 Bn -
8 Alnylam Pharmaceuticals 30.58 Bn 27.27 Bn 992.69 Mn
9 Insmed 27.01 Bn 25.85 Bn 358.27 Mn
10 DiaMedica Therapeutics 360.22 Mn 360.22 Mn -

Historic Data

Download Data
DateValue
Jun 30, 2026 567,000.00
Mar 31, 2026 731,000.00
Dec 31, 2025 481,000.00
Sep 30, 2025 445,000.00
Jun 30, 2025 680,000.00
Mar 31, 2025 649,000.00
Dec 31, 2024 227,000.00
Sep 30, 2024 280,000.00
Jun 30, 2024 568,000.00
Mar 31, 2024 569,000.00
Dec 31, 2023 411,000.00
Sep 30, 2023 396,000.00
Jun 30, 2023 675,000.00
Mar 31, 2023 962,000.00
Dec 31, 2022 209,000.00
Sep 30, 2022 322,000.00
Jun 30, 2022 534,000.00
Mar 31, 2022 793,000.00
Dec 31, 2021 84,000.00
Sep 30, 2021 336,000.00